Xp Medex W Prescription Writing Winter

Front 1

Understand and correctly fill out the elements of a prescription

Back 1

-DATE
-PRESCRIBER IDENTIFICATION

-PATIENT IDENTIFICATION/

-SUPERSCRIPTION/

-INSCRIPTION /

-SUBSCRIPTION/

-SIGNA/

-REFILL INFORMATION

-CONTAINER INFORMATION/

-GENERIC SUBSTITUTIONS

-WARNINGS

-PRESCRIBER SIGNATURE

Front 2

The prescription DO NOT USE list of symbols are: (7ct)

Back 2

-The symbols:

- >

- <

-All abbreviations for drug names

-Apothecary units

- @

-cc

-μg

Front 3

Date

Back 3

the prescription was written

Front 4

Prescriber identification

Back 4

including name,
professional degree,
office address and telephone number, DEA number if required.

Front 5

Patient identification

Back 5

including name, address, age, sex, and weight. Superscription

Front 6

Subscription

Back 6

instructions to the Pharmacist -regarding the dosage form and the number of dosage units to dispense.

-Instructions should be specific about the dosage form, and a quantity must be specified if it is a liquid or semisolid.

For controlled substances:
-quantities should be written
-as words
-as well as numbers
-to guard against alteration.

Front 7

Signa

Back 7

Instructions to the patient.
-Should include how much to take,
-when to take, and
-why it is being taken.

Front 8

Refill information

Back 8

number of times (or time period) the patient may renew prescription without authorization from prescriber.

Front 9

Container information

Back 9

unless the prescriber specifies otherwise, medications will be dispensed in childproof containers.

Front 10

Generic substitutions

Back 10

pharmacists may substitute generic brands unless the prescriber specifies “dispense as written”.

Front 11

Warnings

Back 11

prescription should specify what if any warning labels should be attached to the medication vial. Prescriber’s signature

Front 12

DRUG CATEGORIES: (FDA)
Use-in-Pregnancy
(list the 13 catagories)
5-A’s,
3-C’s,
2-D’s,
G-H-M-O

Back 12

Antibiotics
Anti-infectives
Anticoagulants (Blood Thinners)
Antihistamines
Antilipemics (Cholesterol-Lowering Drugs)
Asthma Drugs-Bronchodilators
Cancer Drugs
Cardiovascular Drugs
Central Nervous System (CNS)
Diuretics
Gastrointestinal Drugs
Hormones
Muscle Relaxants
Other

Front 13

3. Understand and describe the FDA Use-in-Pregnancy ratings. (Table 12-1)

Front 14

The FDA Use-in-Pregnancy ratings Chart Is Categorized by

Back 14

-Name of Drug
-FDA Risk Factor =
(Catagory: A., B., C., D., X.)
-Possible Problems
-What You Need to Know

Front 15

Category A

Back 15

- These drugs have been demonstrated not to pose any risks to human fetuses.

Front 16

Category B

Back 16

- These drugs are believed not to pose any significant risk to human fetuses, based on what has been learned from animal or human studies.

Front 17

Category C

Back 17

- These drugs may or may not be harmful to human fetuses. The data is inconclusive, either because no studies have been done or because any adverse effects that have been demonstrated have shown up in animal rather than human studies.

Front 18

Category D

Back 18

- These drugs are known to pose a threat to human fetuses, but they may be Commonly found in cases where the benefits of using the drug outweighs these risks.

Front 19

Category X

Back 19

- These drugs have been proven to cause fetal abnormalities in humans and should not be used by under any circumstances during pregnancy. (In other words, Category X drugs are FDA-approved, but they are not to be used by pregnant women.)

Front 20

Schedule I drugs Findings required

Back 20

(A) high potential for abuse.
(B) no currently accepted medical use in treatment in the United States.
(C) lack of accepted safety for use under medical supervision.

Hint 20

Control Measures:
-No prescriptions may be written for Schedule I substances,
-such substances are subject to production quotas by the DEA.

Front 21

Schedule II drugs Findings required

Back 21

(A) a high potential for abuse.
(B) has a currently accepted medical use in treatment in the United States or accepted medical use with severe restrictions.
(C) Abuse may lead to severe psychological or physical dependence

Hint 21

Control measures:
-only available by prescription,
-Prescriptions must be written in ink or type written and
-must be signed by the practitioner.
-Verbal prescriptions must be confirmed in writing within 72 hours & -given only in a genuine emergency. -Oral prescriptions are allowed, limited to 30 doses,
-exceptions are made for:
-cancer patients,
- burn victims, etc.
-No refills are allowed.
- Schedule II drugs are subject to production quotas set by the DEA.

Front 22

Schedule III drugs Findings required

Back 22

(A) The drug or other substance has a potential for abuse less than schedules I and II.
(B) a currently accepted medical use in treatment in the United States.
(C) Abuse may lead to moderate or low physical dependence or high psychological dependence.

Hint 22

Control measures:
-only by prescription, -wholesale distribution is somewhat less stringent than Schedule II drugs.
-Schedule III drugs may be refilled up to five times within a six month period, and
-may be oral or written.

Front 23

Schedule IV drugs Findings required:

Back 23

(A) low potential for abuse relative to schedule III.
(B) currently accepted medical use in treatment in the United States. (C) may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III

Hint 23

Control measures:
- similar to Schedule III.
-Prescriptions for Schedule IV drugs
-may be refilled up to five times within a six month period, and
-can be oral or written.

Front 24

Schedule V drugs

Back 24

Findings required:
(A) low potential for abuse relative to the drugs or other substances in schedule IV.
(B) currently accepted medical use in treatment in the United States
(C) may lead to limited physical dependence or psychological dependence relative to schedule IV.

Hint 24

Control measures: Schedule V drugs are sometimes available without a prescription.